Brian K Halak
CIK 1354718 · last filed 2023-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$247.58M
Companies
18
Total Filings
81
Lifetime Open-Market Net
$78.95M
Filer Profile
Reported Address
C/O DOMAIN ASSOCIATESONE PALMER SQUARE
PRINCETON, NJ 08542
Related Filers
JAMES C BLAIR — 123 joint filings, latest 2019-08-08
BRIAN H DOVEY — 123 joint filings, latest 2019-08-08
NICOLE VITULLO — 123 joint filings, latest 2019-08-08
JESSE I TREU — 122 joint filings, latest 2019-08-08
KATHLEEN K SCHOEMAKER — 85 joint filings, latest 2015-08-20
PARTERS VII L P DOMAIN — 42 joint filings, latest 2019-08-08
DP VII ASSOCIATES LP — 35 joint filings, latest 2016-11-03
Domain Partners VIII, L.P. — 19 joint filings, latest 2019-05-13
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
View filings on SEC EDGAR.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALIMERA SCIENCES INC (ALIM) Delisted | Director | 327 | $5.54 | $1.8K | $0 | 15 | 2023-01-06 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | Director | 45,665 | $38.22 | $1.75M | -$19.89M | 10 | 2018-11-06 |
| Evoke Pharma Inc (OMED) Delisted | 10%+ Owner | 959,256 | — | — | -$4.77M | 8 | 2016-04-27 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | 10%+ Owner | 3,553,322 | — | — | $20.65M | 1 | 2015-05-06 |
| Durata Therapeutics, Inc. (DRTX) Delisted | 10%+ Owner | 16,529 | — | — | $7.06M | 2 | 2014-11-18 |
| ATRA | 10%+ Owner | 636 | $9.38 | $6.0K | $141.8K | 1 | 2014-10-21 |
| VCYT | 10%+ Owner | 5,826,588 | $41.52 | $241.92M | $0 | 2 | 2014-09-12 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 1,987,049 | — | — | $0 | 1 | 2014-03-17 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | 10%+ Owner | 97,377 | — | — | $17.01M | 10 | 2014-02-14 |
| TNDM | 10%+ Owner | 318,906 | $17.62 | $5.62M | $0 | 2 | 2013-11-19 |
| Ocera Therapeutics, Inc. (TZYM) Delisted | 10%+ Owner | 15,731 | — | — | $8.00M | 1 | 2013-07-16 |
| Esperion Therapeutics, Inc. (ESPR) Delisted | 10%+ Owner | 1,786,012 | $3.18 | $5.68M | $4.00M | 1 | 2013-07-02 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | 10%+ Owner | 159,896 | — | — | $0 | 3 | 2013-01-18 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | 10%+ Owner | 296,742 | — | — | $18.29M | 12 | 2011-12-22 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 13,958 | $0.08 | $1.1K | $12.11M | 1 | 2011-11-21 |
| ZOGENIX, INC. (ZGNX) Delisted | 10%+ Owner | 21,156 | $26.68 | $564.4K | $16.40M | 2 | 2011-09-20 |
| VNDA | Director | 7,276 | $5.16 | $37.5K | $0 | 4 | 2010-03-30 |
| Volcano Corp (VOLC) Delisted | 10%+ Owner | 60,133 | — | — | -$53.3K | 3 | 2008-06-09 |
Recent Filings · Page 3 of 9
81 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-04-13 | Evoke Pharma Inc (OMED) Delisted | Sell (S) | −450 | -$2.3K | EDGAR |
| 2015-08-20 | Evoke Pharma Inc (OMED) Delisted | Sell (S) | −82,852 | -$581.6K | EDGAR |
| 2015-07-17 | ALIMERA SCIENCES INC (ALIM) Delisted | Other (J) | +1,692 | $0 | EDGAR |
| 2015-06-29 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-25 | ALIMERA SCIENCES INC (ALIM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-06 | Tobira Therapeutics, Inc. (TBRA) Delisted | Buy (P) | +1,944,439 | $20.65M | EDGAR |
| 2015-04-16 | Evoke Pharma Inc (OMED) Delisted | Sell (S) | −351,141 | -$2.56M | EDGAR |
| 2014-11-18 | Durata Therapeutics, Inc. (DRTX) Delisted | Disp (D) | −50,000 | $0 | EDGAR |
| 2014-10-21 | ATRA | Mixed | +111,230 | $141.8K | EDGAR |
| 2014-09-12 | VCYT | Other (J) | −2,100,000 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.